top of page

Publications

2024

 

 

 

 

 

 

 

2023

 

 

 

 

 

 

 

  • W. van Bergen, J. Hevler, W. Wu, M.P. Baggelaar, A.J.R. Heck, Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles. Molecular & Cellular Proteomics, 2023, 22

 
 
 
 
 
 
 
 
 
 
 

 

2022

2019

  • Zhou J., Mock E.D., Martella A., Kantae V., Di X., Burggraaff L., Baggelaar M.P., Al-Ayed K., Bakker A., Florea B.I., Grimm S.H., den Dulk H., Li C.T., Mulder L., Overkleeft H.S., Hankemeier T.., van Westen G.J.P., van der Stelt M. Activity-Based Protein Profiling Identifies α-Ketoamides as Inhibitors for Phospholipase A2 Group XVI ACS Chem. Biol. 2019, 14, 164-16

  • Baggelaar M.P.#, den Dulk H., Florea B.I., Fazio D., Bernabò N., Raspa M., Janssen A.P.A., Scavizzi F., Barboni B., Overkleeft H.S., Maccarrone M., van der Stelt M. # ABHD2 Inhibitor Identified by Activity-Based Protein Profiling Reduces Acrosome Reaction. ACS Chem. Biol. doi: 10.1021/acschembio.9b00640. [Epub ahead of print]. 

2018

  • van Rooden E.J., van Esbroeck A.C.M., Baggelaar M.P., Deng H., Florea B.I., Marques A.R.A., Ottenhoff R., Boot R.G., Overkleeft H.S., Aerts J.M.F.G., van der Stelt M. Chemical Proteomic Analysis of Serine Hydrolase Activity in Niemann-Pick Type C Mouse Brain Front. Neurosci. 2018, 2, 440

  • Baggelaar M.P., Maccarrone M., van der Stelt M.. 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain Prog. Lipid Res. 2018, 71, 1-17. 

  • van Rooden E.J., Florea B.I., Deng H., Baggelaar M.P., van Esbroeck A.C.M., Zhou J., Overkleeft H.S., van der Stelt M. Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification Nat. Protoc. 2018, 13, 752-767

2017

  • Petracca R., Romeo E., Baggelaar M.P., Artola M., Pontis S., Ponzano S., Overkleeft H.S., van der Stelt M., Piomelli D. Novel activity-based probes for N-acylethanolamine acid amidase  Chem. Commun. (Camb) 2017, 53, 11810-11813

  • van Esbroeck A.C.M., Janssen A.P.A., Cognetta A.B. 3rd, Ogasawara D., Shpak G., van der Kroeg M., Kantae V., Baggelaar M.P., de Vrij F.M.S., Deng H., Allarà M., Fezza F., Lin Z., van der Wel T., Soethoudt M., Mock E.D., den Dulk H., Baak I.L., Florea B.I., Hendriks G., De Petrocellis L., Overkleeft H.S., Hankemeier T., De Zeeuw C.I., Di Marzo V., Maccarrone M., Cravatt B.F., Kushner S.A., van der Stelt M. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 Science 2017, 356, 1084-1087. IF: ‎41.04 (S)

  • Deng H., van der Wel T., van den Berg R.J.B.H.N., van den Nieuwendijk A.M.C.H., Janssen F.J., Baggelaar M.P., Overkleeft H.S., van der Stelt M. Chiral disubstituted piperidinyl ureas: a class of dual diacylglycerol lipase-α and ABHD6 inhibitors Medchemcomm. 2017, 8, 982-988

  • Soethoudt M., Grether U., Fingerle J., Grim T.W., Fezza F., de Petrocellis L., Ullmer C., Rothenhäusler B., Perret C., van Gils N., Finlay D., MacDonald C., Chicca A., Gens M.D., Stuart J., de Vries H., Mastrangelo N., Xia L., Alachouzos G., Baggelaar M.P., Martella A., Mock E.D., Deng H., Heitman L.H., Connor M., Di Marzo V., Gertsch J., Lichtman A.H., Maccarrone M., Pacher P., Glass M., van der Stelt M. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity Nat. Commun. 2017, 8, 13958

  • Deng H., Kooijman S., van den Nieuwendijk A.M., Ogasawara D., van der Wel T., van Dalen F., Baggelaar M.P., Janssen F.J., van den Berg R.J., den Dulk H., Cravatt B.F., Overkleeft H.S., Rensen P.C., van der Stelt M. Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding J. Med. Chem. 2017, 60, 428-440

  • Baggelaar MP, van Esbroeck AC, van Rooden EJ, Florea BI, Overkleeft HS, Marsicano G, Chaouloff F, van der Stelt M. # Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases ACS Chem. Biol. 2017, 12, 852-861. 

2016

  • Ogasawara D., Deng H., Viader A., Baggelaar M.P., Breman A., den Dulk H., van den Nieuwendijk A.M., Soethoudt M., van der Wel T., Zhou J., Overkleeft H.S., Sanchez-Alavez M., Mo S., Nguyen W., Conti B., Liu X., Chen Y., Liu Q.S., Cravatt B.F., van der Stelt M. Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proc. Natl. Acad. Sci. U S A 2016, 113, 26-33

  • Mukhopadhyay P, Baggelaar M.P., Erdelyi K, Cao Z, Cinar R, Fezza F, Ignatowska-Janlowska B, Wilkerson J, van Gils N, Hansen T, Ruben M, Soethoudt M, Heitman L, Kunos G, Maccarrone M, Lichtman A, Pacher P, Van der Stelt M. The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. Br. J. Pharmacol. 2016, 173, 446-58

2015

  • Baggelaar M.P., Chameau P.J., Kantae V., Hummel J., Hsu K.L., Janssen F., van der Wel T., Soethoudt M., Deng H., den Dulk H., Allarà M., Florea B.I., Di Marzo V., Wadman W.J., Kruse C.G., Overkleeft H.S., Hankemeier T., Werkman T.R., Cravatt B.F., van der Stelt M. # Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons. J. Am. Chem. Soc. 2015, 137, 8851-7.

  • Janssen FJ, Baggelaar M.P., Hummel JJ, Overkleeft HS, Cravatt BF, Boger DL, van der Stelt M. Comprehensive Analysis of Structure-Activity Relationships of α-Ketoheterocycles as sn-1-Diacylglycerol Lipase α Inhibitors. J. Med. Chem. 2015, 58, 9742-53

  • Ouairy CM, Ferraz MJ, Boot RG, Baggelaar M.P., van der Stelt M, Appelman M, van der Marel GA, Florea BI, Aerts JM, Overkleeft HS. Development of an acid ceramidase activity-based probe. Chem. Commun. (Camb). 2015, 51, 6161-3

  • van der Wel T, Janssen FJ, Baggelaar M.P., Deng H, den Dulk H, Overkleeft HS, van der Stelt M. A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α. J. Lipid Res. 2015, 56, 927-35

2014

  1. Janssen FJ, Deng H, Baggelaar M.P., Allarà M, van der Wel T, den Dulk H, Ligresti A, van Esbroeck AC, McGuire R, Di Marzo V, Overkleeft HS, van der Stelt M. Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6. J. Med. Chem. 2014, 57, 6610-22

2013

  • Baggelaar M.P., Janssen F.J., van Esbroeck A.C., den Dulk H., Allarà M., Hoogendoorn S., McGuire R., Florea B.I., Meeuwenoord N., van den Elst H., van der Marel G.A., Brouwer J., Di Marzo V., Overkleeft H.S., van der Stelt M. # Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-α in brain. Angew. Chem. Int. Ed. Engl. 2013, 52, 12081-5

  • Baggelaar M.P., Huang Y., Feringa B.L., Dekker F.J., Minnaard A.J. Catalytic asymmetric total synthesis of (S)-(-)-zearalenone, a novel lipoxygenase inhibitor. Bioorg. Med. Chem. 2013, 21, 5271-4.

2012

  • Barroso S, Castelli R, Baggelaar M.P., Geerdink D, ter Horst B, Casas-Arce E, Overkleeft HS, van der Marel GA, Codée JD, Minnaard AJ. Total synthesis of the triglycosyl phenolic glycolipid PGL-tb1 from Mycobacterium tuberculosis. Angew. Chem. Int. Ed. Engl. 2012, 51, 11774-7

PhosID ABPP.jpg
recent advancements.jpg
TOC Samiksha et al 2023.jpeg
Graphical_abstract.jpg
bottom of page